Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Akil Merchant

Akil Merchant

Cedars-Sinai Medical Center
Phase I/II study of LYL314, a novel CD19/CD20-targeting CAR T-cell, for R/R LBCL 1:25
Phase I/II study of LYL314, a novel CD19/CD20-targeting CAR T-cell, for R/R LBCL
Akil Merchant • 20 Jun 2025
The content of VJHemOnc is intended for healthcare professionals